Anti-interferon-.alpha. antibodies

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 37/06 (2006.01) C07K 16/24 (2006.01) C12N 5/20 (2006.01) G01N 33/564 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2437161

The present invention relates generally to the generation and characterization of neutralizing anti-IFN-.alpha. monoclonal antibodies with broad reactivity against various IFN-.alpha. subtypes. The invention further relates to the use of such anti-IFN-.alpha. antibodies in the diagnosis and treatment of disorders associated with increased expression of IFN-.alpha., in particular, autoimmune disorders such as insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE).

La présente invention concerne d'une façon générale la génération et la caractérisation d'anticorps monoclonaux anti-IFN-.alpha. neutralisants qui possèdent une grande réactivité contre divers sous types de IFN-.alpha.. Cette invention concerne aussi l'utilisation de ces anticorps anti-IFN dans le diagnostic et le traitement de troubles associés à une augmentation de l'expression de IFN-.alpha., en particulier les troubles autoimmuns tels que le diabète insulino-dépendant (DID) et que le lupus érythémateux disséminé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-interferon-.alpha. antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-interferon-.alpha. antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-interferon-.alpha. antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2037094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.